{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-05T15:47:57.663318+00:00","company":{"ticker":"MLSS","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC."},"pagination":{"limit":100,"returned":12,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"auditor_change","fact_key":"5ccd0602827f189d1125c6faba2ddb251947c343","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2026-05-06T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Grassi & Co., CPAs, P.C.","disagreement_text":"During the fiscal years ended December 31, 2025 and 2024 and through April 30, 2026, neither the Company nor anyone acting on its behalf consulted with Grassi regarding either (i) the application of accounting principles to a specific transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company's financial statements, and no written report was provided to the Company or oral advice was provided that Grassi concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of either a disagreement (as defined in Item 304(a)(1)(iv","effective_date":"2026-05-15","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"MILESTONE SCIENTIFIC INC. engaged Grassi & Co., CPAs, P.C. as its auditor.","evidence_excerpt":"The Company engaged Grassi & Co., CPAs, P.C. to be the independent registered public accounting firm to the Company for","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001493152-26-021512","anchor_url":"https://secwatch.observer/filing/0001493152-26-021512#claim-5ccd0602827f189d1125c6faba2ddb251947c343","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226021512/0001493152-26-021512-index.htm"},{"fact_type":"auditor_change","fact_key":"80c8774df82e02f74a8105fe9e7b326e5a19fdea","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2026-05-06T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"CBIZ CPAs P.C.","disagreement_text":"During the Company's most recent fiscal year ended December 31, 2025, and the subsequent interim period through April 30, 2026, there were no disagreements between the Company and CBIZ CPAs on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of CBIZ CPAs, would have caused it to make a reference to the subject matter of the disagreements in connection with its reports on the Company's financial statements for such periods.","effective_date":"2026-05-15","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Grassi & Co., CPAs, P.C."},"claim":"MILESTONE SCIENTIFIC INC. dismissed CBIZ CPAs P.C. as its auditor.","evidence_excerpt":"(the “Company”) approved the dismissal of\nCBIZ CPAs P.C. (“CBIZ CPAs”) as the independent registered public accounting firm to the Company effective as of May 15,","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001493152-26-021512","anchor_url":"https://secwatch.observer/filing/0001493152-26-021512#claim-80c8774df82e02f74a8105fe9e7b326e5a19fdea","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226021512/0001493152-26-021512-index.htm"},{"fact_type":"material_agreement","fact_key":"145b02728c8703acf0e452f7d8912402528fb4ae","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2026-04-21T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase Agreement","agreement_type":"equity_purchase","counterparty":"the purchasers named therein (the \"Purchasers\")","effective_date":"2026-04-20","item_codes_triggered":["1.01"],"value_text":"$2,150,000"},"claim":"MILESTONE SCIENTIFIC INC. entered into Purchase Agreement with the purchasers named therein (the \"Purchasers\") valued at $2,150,000 (effective 2026-04-20).","evidence_excerpt":"On April 20, 2026, Milestone Scientific Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of an aggregate of 7,962,963 units (the “Units”), with each Unit consisting of (i) one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) one warrant to purchase one share of Common Stock (each, a “Warrant”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-018231","anchor_url":"https://secwatch.observer/filing/0001493152-26-018231#claim-145b02728c8703acf0e452f7d8912402528fb4ae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226018231/0001493152-26-018231-index.htm"},{"fact_type":"material_agreement","fact_key":"d9d94df3b6b6c3460f79a1b61870c9e0274a6868","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2026-04-02T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment","agreement_type":"other","counterparty":"Innovest S.p.A.","effective_date":"2026-03-31","item_codes_triggered":["1.01"],"value_text":null},"claim":"MILESTONE SCIENTIFIC INC. amended Amendment with Innovest S.p.A. (effective 2026-03-31).","evidence_excerpt":"On March 31, 2026, Milestone Scientific Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Amended and Restated Memorandum of Understanding, dated January 13, 2026 (the “MOU”), with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-014892","anchor_url":"https://secwatch.observer/filing/0001493152-26-014892#claim-d9d94df3b6b6c3460f79a1b61870c9e0274a6868","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226014892/0001493152-26-014892-index.htm"},{"fact_type":"governance_change","fact_key":"1024d86069cf4c1c791fdac798108b0ccff569f3","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2026-03-11T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2026-03-10","item_codes_triggered":["5.03"],"summary_text":"The Company amended its Restated Certificate of Incorporation to increase authorized shares of common stock from 100,000,000 to 125,000,000."},"claim":"MILESTONE SCIENTIFIC INC.: The Company amended its Restated Certificate of Incorporation to increase authorized shares of common stock from 100,000,000 to 125,000,000 (effective 2026-03-10).","evidence_excerpt":"As a result of the stockholder approval, the Company filed a Certificate of Amendment of its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on March 10, 2026, which amendment became effective on filing.","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001493152-26-009581","anchor_url":"https://secwatch.observer/filing/0001493152-26-009581#claim-1024d86069cf4c1c791fdac798108b0ccff569f3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226009581/0001493152-26-009581-index.htm"},{"fact_type":"material_agreement","fact_key":"301fb9b1032dd4e52f65688f4906a18e5c956c8c","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2026-01-20T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Amended and Restated Memorandum of Understanding","agreement_type":"other","counterparty":"Innovest S.p.A.","effective_date":"2026-01-15","item_codes_triggered":["1.01"],"value_text":null},"claim":"MILESTONE SCIENTIFIC INC. entered into Amended and Restated Memorandum of Understanding with Innovest S.p.A. (effective 2026-01-15).","evidence_excerpt":"On January 15, 2026, Milestone Scientific Inc. (“the Company”) entered into an Amended and Restated Memorandum of Understanding (the “MOU”) with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-002934","anchor_url":"https://secwatch.observer/filing/0001493152-26-002934#claim-301fb9b1032dd4e52f65688f4906a18e5c956c8c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226002934/0001493152-26-002934-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"a5cfb01f0519dd512a6f9743ba77aa3460df77cf","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2025-10-14T23:59:59+00:00","payload":{"company_response":"intends to submit compliance plan","compliance_status":"plan_due","cure_deadline":"2027-04-08","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nyse_american","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-10-08","notice_type":"deficiency_notice","plan_due_date":"2025-11-07","raw_rule_text":"Section(s) 1003(a)(ii), and (iii) of the NYSE American Company Guide","reported_value":null,"rule_numbers":["1003(a)(ii)","1003(a)(iii)"],"rules_cited_in_text":true},"claim":"MILESTONE SCIENTIFIC INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).","evidence_excerpt":"October 8, 2025, Milestone Scientific Inc. (“the Company”) received a letter from NYSE American LLC (“NYSE American”\nor the “Exchange”) stating that the Company is not in compliance with the continued listing standards as outlined in Section(s)\n1003(a)(ii), and (iii) of the NYSE American Company Guide (the “Company Guide”). To maintain its listing, the Company must\nsubmit a plan of compliance by November 7, 2025, outlining the actions it has taken or will take to regain compliance. If the plan is\naccepted, the Company may be able to continue its listing but will be subject to periodic reviews","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-017919","anchor_url":"https://secwatch.observer/filing/0001493152-25-017919#claim-a5cfb01f0519dd512a6f9743ba77aa3460df77cf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315225017919/0001493152-25-017919-index.htm"},{"fact_type":"executive_change","fact_key":"435ab034b8","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2025-05-19T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-14","interim":false,"role":"independent director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Shanth Thiyagalingam was appointed as independent director at MILESTONE SCIENTIFIC INC..","evidence_excerpt":"On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-25-017562","anchor_url":"https://secwatch.observer/filing/0001437749-25-017562#claim-435ab034b8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000143774925017562/0001437749-25-017562-index.htm"},{"fact_type":"executive_change","fact_key":"c7f5d5d5f4","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2025-01-13T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-01-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Giandomenico Trombetta resigned as Director at MILESTONE SCIENTIFIC INC..","evidence_excerpt":"On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001437749-25-000987","anchor_url":"https://secwatch.observer/filing/0001437749-25-000987#claim-c7f5d5d5f4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000143774925000987/0001437749-25-000987-index.htm"},{"fact_type":"executive_change","fact_key":"430cf23688","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2024-11-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-01","interim":true,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Neal Goldman was appointed as Interim Chief Executive Officer at MILESTONE SCIENTIFIC INC..","evidence_excerpt":"Mr. Neal Goldman, the Chairman of the Board of Directors of the Company, has been appointed the Interim Chief Executive Officer, effective on Mr. Haverhals retirement.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001437749-24-035286","anchor_url":"https://secwatch.observer/filing/0001437749-24-035286#claim-430cf23688","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000143774924035286/0001437749-24-035286-index.htm"},{"fact_type":"executive_change","fact_key":"82b480d68c","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2024-11-14T23:59:59+00:00","payload":{"action":"retire","action_category":"departure","departure_tone":"retirement","effective_date":"2024-12-31","interim":true,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Neal Goldman","successor_named":true},"claim":"Arjan Haverhals departed as Chief Executive Officer at MILESTONE SCIENTIFIC INC..","evidence_excerpt":"On November 8, 2024, Mr. Arjan Haverhals, the Chief Executive Officer of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he intends to retire as an officer from the Company upon the expiration of, and not seek the renewal of, his employment agreement, on December 31, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001437749-24-035286","anchor_url":"https://secwatch.observer/filing/0001437749-24-035286#claim-82b480d68c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000143774924035286/0001437749-24-035286-index.htm"},{"fact_type":"material_agreement","fact_key":"fe0c778b0140c3030794c8fa24b1affb90a3c435","cik":855683,"ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2024-04-09T23:59:59+00:00","payload":{"action":"entry","agreement_name":null,"agreement_type":"other","counterparty":"Comcast Corporation","effective_date":"2024-02-02","item_codes_triggered":["1.01"],"value_text":"$1,983,095"},"claim":null,"evidence_excerpt":"On February 2, 2024, the Company entered into an agreement to sell its unused NOLs and R & D tax credits to Comcast Corporation.","confidence":0.4,"filing_url":"https://secwatch.observer/filing/0001437749-24-011488","anchor_url":"https://secwatch.observer/filing/0001437749-24-011488#claim-fe0c778b0140c3030794c8fa24b1affb90a3c435","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/855683/000143774924011488/0001437749-24-011488-index.htm"}]}